{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Genzyme", "item": "https://www.patentleaderboard.com/2021/company/genzyme"}, {"@type": "ListItem", "position": 4, "name": "C. Michael Philbrook", "item": "https://www.patentleaderboard.com/2021/inventor/fl:c._ln:philbrook-1"}]}

Home › 2021 › Genzyme › C. Michael Philbrook

C. Michael Philbrook — 1 Patent in 2021

GEGenzyme: 1 patents #20 of 122Top 20%

Boston, MA: #402 of 1,168 inventorsTop 35%

Massachusetts: #4,998 of 14,123 inventorsTop 40%

Overall (2021): #508,526 of 548,734Top 95%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
11110055	Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors	Harvey Lieberman, Donglai Yang, Michael Santos, Chris Ho	2021-09-07

C. Michael Philbrook — 1 Patent in 2021

Issued Patents 2021

Patent Widget